New gel could help heal wounds in rare skin disease
NCT ID NCT06917690
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a gel called Oleogel-S10 on skin wounds in people with inherited epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. The trial includes 6 Japanese children and adults with junctional or dystrophic EB. Participants apply the gel to wounds every few days for 45 days, with follow-up visits every two weeks. The goal is to see if the gel helps wounds close faster and is safe to use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Oleogel-S10 (a topical gel)
What this could lead to
If successful, this gel could become a treatment option to help close and heal skin wounds in people with epidermolysis bullosa, reducing pain and infection risk.
What could go wrong
This is a small, early-phase trial with only 6 participants, so results may not apply to everyone. The gel may not work for all wound types, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ABNORMALITIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fukuoka Children's Hospital - Dermatology
RECRUITINGFukuoka, Japan
Contact Email: •••••@•••••
-
Hokkaido University Hospital
RECRUITINGSapporo, Japan
Contact Email: •••••@•••••
-
Kobe University Hospital
RECRUITINGKobe, Japan
Contact Email: •••••@•••••
-
Kurume University Hospital
RECRUITINGFukuoka, Japan
Contact Email: •••••@•••••
-
Niigata University Medical and Dental Hospital
RECRUITINGNiigata, Japan
Contact Email: •••••@•••••
-
Toho University Omori Medical Center
RECRUITINGŌta-ku, Japan
Contact Email: •••••@•••••